US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 1064.190
  • +3.330+0.31%
Close Jul 25 16:00 ET
  • 1074.783
  • +10.593+1.00%
Post 20:02 ET
117.26BMarket Cap31.42P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regeneron Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 1, 2024

Revenue(YoY)

3.39B

+7.25%
EPS(YoY)

8.24

-3.01%
Analyst Rating

Strong Buy

Jul 25, 2024

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 21 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.569B--
Aug 1, 20242024/Q2-- / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
Feb 2, 20242023/Q43.434B / 3.287B--
Nov 2, 20232023/Q33.363B / 3.222B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.569B--
Aug 1, 20242024/Q2-- / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
Feb 2, 20242023/Q43.434B / 3.287B--
Nov 2, 20232023/Q33.363B / 3.222B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

  • Regeneron Pharmaceuticals | 10-Q: Quarterly report

    May 2 07:18 ET

  • Regeneron Pharmaceuticals | 10-K: Annual report

    Feb 5 09:17 ET

  • Regeneron Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 07:22 ET

  • Regeneron Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 06:56 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 25, 2024

    Strong Buy

    • Buy

      95.24%

    • Hold

      4.76%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg